In addition, Gigante et al. revealed that CD8+ T cells from ccRCC patients expressed reduced levels of anti-apoptotic and proliferation-associated gene products when compared with normal donor T cells due to miR-29b and miR-198 overexpression, thus leading to immune dysfunction [44]. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.